Related references
Note: Only part of the references are listed.How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies
David Wu et al.
HAEMATOLOGICA (2020)
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Anna L. Brown et al.
BLOOD ADVANCES (2020)
Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications
Michael E. Kallen et al.
SEMINARS IN HEMATOLOGY (2019)
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease
Andres E. Quesada et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Hereditary myeloid malignancies
Hind Rafei et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)
Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia
Pallavi Galera et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)
Germline Predisposition to Hematolymphoid Neoplasia 2017 Society for Hematopathology/European Association for Haematopathology Workshop Report
Olga K. Weinberg et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia
Yoshihiro Gocho et al.
BLOOD (2019)
Stopping Leukemia in Its Tracks: Should Preemptive Hematopoietic Stem-Cell Transplantation be Offered to Patients at Increased Genetic Risk for Acute Myeloid Leukemia?
Kayla V. Hamilton et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Germline DDX41 mutations define a significant entity within adult MDS/AML patients
Marie Sebert et al.
BLOOD (2019)
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants
Xi Luo et al.
BLOOD ADVANCES (2019)
GATA2 Deficiency Early identification for improved clinical outcomes
Kristen Cole et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2019)
Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes
Eric Padron et al.
BLOOD (2018)
Germline GATA2 Mutation and Bone Marrow Failure
Lisa J. McReynolds et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Kiran Tawana et al.
LEUKEMIA (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Myelodysplastic Syndromes, Version 2.2017 Clinical Practice Guidelines in Oncology
Peter L. Greenberg et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Myeloid neoplasms with germline DDX41 mutation
Jesse J. C. Cheah et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes
L. Guidugli et al.
LEUKEMIA (2017)
RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)
Brigitte Schlegelberger et al.
SEMINARS IN HEMATOLOGY (2017)
DDX41-related myeloid neoplasia
Jaroslaw P. Maciejewski et al.
SEMINARS IN HEMATOLOGY (2017)
Familial CEBPA-mutated acute myeloid leukemia
Kiran Tawana et al.
SEMINARS IN HEMATOLOGY (2017)
Ethical considerations in genomic testing for hematologic disorders
Jonathan M. Marron et al.
BLOOD (2017)
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies
Maya Lewinsohn et al.
BLOOD (2016)
Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family
Anand Pathak et al.
HAEMATOLOGICA (2016)
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia
I. Antony-Debre et al.
LEUKEMIA (2016)
Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family
Anand Pathak et al.
HAEMATOLOGICA (2016)
Correspondence Regarding the Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues
Jane E. Churpek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
How I diagnose and manage individuals at risk for inherited myeloid malignancies
Michael W. Drazer et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)
Courtney D. DiNardo et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients
Sioban B. Keel et al.
HAEMATOLOGICA (2016)
Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients
Sioban B. Keel et al.
HAEMATOLOGICA (2016)
Disease evolution and outcomes in familial AML with germline CEBPA mutations
Kiran Tawana et al.
BLOOD (2015)
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
Jane E. Churpek et al.
BLOOD (2015)
Germ line ETV6 mutations in familial thrombocytopenia and hematologic malignancy
Michael Y. Zhang et al.
NATURE GENETICS (2015)
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
Michael A. Spinner et al.
BLOOD (2014)
Recurrent CDC25C mutations drive malignant transformation in FPD/AML
Akihide Yoshimi et al.
NATURE COMMUNICATIONS (2014)
Concomitant germ-line RUNX1 and acquired ASXL1 mutations in a T-cell acute lymphoblastic leukemia
Thomas Prebet et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Share Paper
